Tenet Healthcare
Stock Forecast, Prediction & Price Target
Tenet Healthcare (THC) stock Price Target by analysts
Tenet Healthcare (THC) stock Price Target by analysts
Average Price Target
$159
Potential downside: -10.68%
Tenet Healthcare price prediction
What is Tenet Healthcare stock analysts` prediction?
Tenet Healthcare stock forecast: Based on 2 Wall Street analysts` predicted price targets for Tenet Healthcare in the last 3 months, the avarage price target is $159, with a high forecast of $NaN. The average price target represents a -10.68% change from the last price of $178.03.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Tenet Healthcare stock Price Target by analysts
Full breakdown of analysts given Tenet Healthcare price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jamie Perse Goldman Sachs | 0% 0/2 | 9 months ago | $140 -21.36% downside | $139.1 | TheFly | Previous targets (1) |
Justin Lake Wolfe Research | 33.33% 1/3 | 10 months ago | $178 -0.01% downside | $156.2 | StreetInsider | Previous targets (2) |
Ann Hynes Mizuho Securities | 33.33% 1/3 | about 1 year ago | $170 -4.51% downside | $151.63 | StreetInsider | Previous targets (2) |
David MacDonald Truist Financial | 0% 0/2 | about 1 year ago | $170 -4.51% downside | $147.68 | TheFly | Previous targets (1) |
David MacDonald Truist Financial | 0% 0/2 | about 1 year ago | $155 -12.93% downside | $132.11 | TheFly | Previous targets (1) |
Andrew Mok Barclays | 0% 0/2 | about 1 year ago | $156 -12.37% downside | $130.97 | TheFly | Previous targets (1) |
Pito Chickering Deutsche Bank | 25% 1/4 | about 1 year ago | $155 -12.93% downside | $138.3 | StreetInsider | Previous targets (3) |
Jamie Perse Goldman Sachs | 0% 0/2 | about 1 year ago | $156 -12.37% downside | $136.4 | StreetInsider | Previous targets (1) |
Pito Chickering Deutsche Bank | 25% 1/4 | over 1 year ago | $150 -15.74% downside | $131.55 | StreetInsider | Previous targets (3) |
Michael Ha Robert W. Baird | 0% 0/1 | over 1 year ago | $153 -14.05% downside | $131.55 | TheFly | Previous targets (0) |
Andrew Mok Barclays | 0% 0/2 | over 1 year ago | $147 -17.42% downside | $115.95 | TheFly | Previous targets (1) |
Ben Hendrix RBC Capital | 50% 1/2 | over 1 year ago | $136 -23.60% downside | $115.11 | StreetInsider | Previous targets (1) |
Ann Hynes Mizuho Securities | 33.33% 1/3 | over 1 year ago | $130 -26.97% downside | $115.46 | StreetInsider | Previous targets (2) |
Scott Fidel Stephens | 0% 0/1 | over 1 year ago | $122 -31.47% downside | $112.29 | TheFly | Previous targets (0) |
Pito Chickering Deutsche Bank | 25% 1/4 | over 1 year ago | $126 -29.22% downside | $101.82 | StreetInsider | Previous targets (3) |
Justin Lake Wolfe Research | 33.33% 1/3 | over 1 year ago | $122 -31.47% downside | $102.32 | StreetInsider | Previous targets (2) |
Unknown Wells Fargo | N/A | over 2 years ago | $59 -66.85% downside | $48.98 | Benzinga | N/A |
Andrew Mok CFA UBS | 100% 1/1 | almost 3 years ago | $47 -73.59% downside | $39.01 | StreetInsider | Previous targets (0) |
Unknown Leerink Partners | N/A | about 3 years ago | $93 -47.76% downside | $61.39 | Benzinga | N/A |
Ann Hynes Mizuho Securities | 33.33% 1/3 | about 3 years ago | $80 -55.06% downside | $64.96 | Pulse 2.0 | Previous targets (2) |
Unknown Mizuho Securities | N/A | about 3 years ago | $80 -55.06% downside | $65.64 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $91 -48.88% downside | $64.21 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $135 -24.17% downside | $62.74 | Benzinga | N/A |
Unknown RBC Capital | N/A | about 3 years ago | $99 -44.39% downside | $62.18 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $88 -50.57% downside | $63.12 | Benzinga | N/A |
Unknown Citigroup | N/A | about 3 years ago | $99 -44.39% downside | $64.86 | Benzinga | N/A |
Unknown Truist Financial | N/A | about 3 years ago | $80 -55.06% downside | $62.99 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $68 -61.80% downside | $53.43 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | about 3 years ago | $93 -47.76% downside | $54.15 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $110 -38.21% downside | $55.14 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $90 -49.44% downside | $53.33 | Benzinga | N/A |
Unknown Mizuho Securities | N/A | about 3 years ago | $63 -64.61% downside | $52.56 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $90 -49.44% downside | $75.29 | Benzinga | N/A |
Unknown Citigroup | N/A | over 3 years ago | $110 -38.21% downside | $74.85 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | over 3 years ago | $110 -38.21% downside | $76.38 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $110 -38.21% downside | $79.89 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $104 -41.58% downside | $86.67 | Benzinga | N/A |
Unknown Barclays | N/A | over 3 years ago | $104 -41.58% downside | $79.78 | Benzinga | N/A |
Whit Mayo Leerink Partners | 100% 1/1 | over 3 years ago | $100 -43.82% downside | $82.22 | TheFly | Previous targets (0) |
Ben Hendrix RBC Capital | 50% 1/2 | over 3 years ago | $89 -50.00% downside | $82.22 | TipRanks Contributor | Previous targets (1) |
Pito Chickering Deutsche Bank | 25% 1/4 | over 3 years ago | $100 -43.82% downside | $74.07 | TheFly | Previous targets (3) |
John Ransom Raymond James | 100% 1/1 | over 3 years ago | $120 -32.59% downside | $78.42 | TheFly | Previous targets (0) |
Jason Cassorla Citigroup | 100% 1/1 | over 3 years ago | $96 -46.07% downside | $74.55 | TheFly | Previous targets (0) |
Kevin Fischbeck Bank of America Securities | 100% 1/1 | over 3 years ago | $100 -43.82% downside | $74.88 | StreetInsider | Previous targets (0) |
Justin Lake Wolfe Research | 33.33% 1/3 | about 4 years ago | $70 -60.68% downside | $68.58 | StreetInsider | Previous targets (2) |
Tenet Healthcare Financial Estimates
Tenet Healthcare Revenue Estimates
Tenet Healthcare EBITDA Estimates
Tenet Healthcare Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $19.48B N/A | $19.17B -1.59% | $20.54B 7.16% | Avg: $21.26B Low: $20.96B High: $21.55B avg. 3.49% | Avg: $22.31B Low: $22.05B High: $22.93B avg. 4.93% | Avg: $23.01B Low: $22.74B High: $23.64B avg. 3.11% | |
Net Income
% change YoY
| $1.47B N/A | $1B -32.29% | $611M -38.9% | Avg: $890.8M Low: $756.65M High: $1.22B avg. 45.79% | Avg: $964.25M Low: $859.36M High: $1.34B avg. 8.24% | Avg: $893.94M Low: $880.24M High: $926.07M avg. -7.29% | |
EBITDA
% change YoY
| $3.49B N/A | $3.47B -0.48% | $3.38B -2.61% | Avg: $3.60B Low: $3.55B High: $3.65B avg. 6.32% | Avg: $3.78B Low: $3.73B High: $3.88B avg. 4.93% | Avg: $3.89B Low: $3.85B High: $4.00B avg. 3.11% | |
EPS
% change YoY
| $13.83 N/A | $9.35 -32.39% | $5.88 -37.11% | Avg: $8.91 Low: $7.22 High: $11.66 avg. 51.60% | Avg: $9.86 Low: $8.2 High: $12.84 avg. 10.56% | Avg: $8.53 Low: $8.4 High: $8.84 avg. -13.45% | |
Operating Expenses
% change YoY
| $13.74B N/A | $13.48B -1.88% | $14.44B 7.10% | Avg: $9.82B Low: $9.68B High: $9.96B avg. -31.99% | Avg: $10.31B Low: $10.18B High: $10.59B avg. 4.93% | Avg: $10.63B Low: $10.50B High: $10.92B avg. 3.11% | |
FAQ
What is Tenet Healthcare stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.58% in 2025-2027.
We have gathered data from 11 analysts. Their low estimate is 756.65M, average is 890.8M and high is 1.22B.
What is Tenet Healthcare stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.85% in 2025-2027.
We have gathered data from 14 analysts. Their low revenue estimate is $20.96B, average is $21.26B and high is $21.55B.
What is Tenet Healthcare stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.23% in 2025-2027.
We have gathered data from 11 analysts. Their low earnings per share estimate is $7.22, average is $8.91 and high is $11.66.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Tenet Healthcare stock. The most successful analyst is Jamie Perse.